Global Crispr Genomic Cure Supply, Demand and Key Producers, 2023-2029

Description

The global Crispr Genomic Cure market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Crispr Genomic Cure demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Crispr Genomic Cure, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Crispr Genomic Cure that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Crispr Genomic Cure total market, 2018-2029, (USD Million)
Global Crispr Genomic Cure total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Crispr Genomic Cure total market, key domestic companies and share, (USD Million)
Global Crispr Genomic Cure revenue by player and market share 2018-2023, (USD Million)
Global Crispr Genomic Cure total market by Type, CAGR, 2018-2029, (USD Million)
Global Crispr Genomic Cure total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Crispr Genomic Cure market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abcam, Applied StemCel, Beam Therapeutics, CALYXT, Cellecta, Cellectis, CRISPR Therapeutics AG, Editas Medicine and ERS ​​Genomics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Crispr Genomic Cure market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Crispr Genomic Cure Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Crispr Genomic Cure Market, Segmentation by Type
    gRNA Design and Vector Construction
    Cell Line and Engineering
    Others

Global Crispr Genomic Cure Market, Segmentation by Application
    Biomedical
    Pharmaceutical
    Agricultural
    Others

Companies Profiled:
    Abcam
    Applied StemCel
    Beam Therapeutics
    CALYXT
    Cellecta
    Cellectis
    CRISPR Therapeutics AG
    Editas Medicine
    ERS ​​Genomics
    Integrated DNA Technologies
    Intellia Therapeutics
    Merck KGaA
    New England Biolabs
    Precision BioSciences
    Sangamo Therapeutics

Key Questions Answered
1. How big is the global Crispr Genomic Cure market?
2. What is the demand of the global Crispr Genomic Cure market?
3. What is the year over year growth of the global Crispr Genomic Cure market?
4. What is the total value of the global Crispr Genomic Cure market?
5. Who are the major players in the global Crispr Genomic Cure market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Crispr Genomic Cure Introduction
    1.2 World Crispr Genomic Cure Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Crispr Genomic Cure Total Market by Region (by Headquarter Location)
        1.3.1 World Crispr Genomic Cure Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Crispr Genomic Cure Market Size (2018-2029)
        1.3.3 China Crispr Genomic Cure Market Size (2018-2029)
        1.3.4 Europe Crispr Genomic Cure Market Size (2018-2029)
        1.3.5 Japan Crispr Genomic Cure Market Size (2018-2029)
        1.3.6 South Korea Crispr Genomic Cure Market Size (2018-2029)
        1.3.7 ASEAN Crispr Genomic Cure Market Size (2018-2029)
        1.3.8 India Crispr Genomic Cure Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Crispr Genomic Cure Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Crispr Genomic Cure Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Crispr Genomic Cure Consumption Value (2018-2029)
    2.2 World Crispr Genomic Cure Consumption Value by Region
        2.2.1 World Crispr Genomic Cure Consumption Value by Region (2018-2023)
        2.2.2 World Crispr Genomic Cure Consumption Value Forecast by Region (2024-2029)
    2.3 United States Crispr Genomic Cure Consumption Value (2018-2029)
    2.4 China Crispr Genomic Cure Consumption Value (2018-2029)
    2.5 Europe Crispr Genomic Cure Consumption Value (2018-2029)
    2.6 Japan Crispr Genomic Cure Consumption Value (2018-2029)
    2.7 South Korea Crispr Genomic Cure Consumption Value (2018-2029)
    2.8 ASEAN Crispr Genomic Cure Consumption Value (2018-2029)
    2.9 India Crispr Genomic Cure Consumption Value (2018-2029)

3 World Crispr Genomic Cure Companies Competitive Analysis
    3.1 World Crispr Genomic Cure Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Crispr Genomic Cure Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Crispr Genomic Cure in 2022
        3.2.3 Global Concentration Ratios (CR8) for Crispr Genomic Cure in 2022
    3.3 Crispr Genomic Cure Company Evaluation Quadrant
    3.4 Crispr Genomic Cure Market: Overall Company Footprint Analysis
        3.4.1 Crispr Genomic Cure Market: Region Footprint
        3.4.2 Crispr Genomic Cure Market: Company Product Type Footprint
        3.4.3 Crispr Genomic Cure Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Crispr Genomic Cure Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Crispr Genomic Cure Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Crispr Genomic Cure Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Crispr Genomic Cure Consumption Value Comparison
        4.2.1 United States VS China: Crispr Genomic Cure Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Crispr Genomic Cure Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Crispr Genomic Cure Companies and Market Share, 2018-2023
        4.3.1 United States Based Crispr Genomic Cure Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Crispr Genomic Cure Revenue, (2018-2023)
    4.4 China Based Companies Crispr Genomic Cure Revenue and Market Share, 2018-2023
        4.4.1 China Based Crispr Genomic Cure Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Crispr Genomic Cure Revenue, (2018-2023)
    4.5 Rest of World Based Crispr Genomic Cure Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Crispr Genomic Cure Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Crispr Genomic Cure Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Crispr Genomic Cure Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 gRNA Design and Vector Construction
        5.2.2 Cell Line and Engineering
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Crispr Genomic Cure Market Size by Type (2018-2023)
        5.3.2 World Crispr Genomic Cure Market Size by Type (2024-2029)
        5.3.3 World Crispr Genomic Cure Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Crispr Genomic Cure Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Biomedical
        6.2.2 Pharmaceutical
        6.2.3 Agricultural
        6.2.4 Others
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World Crispr Genomic Cure Market Size by Application (2018-2023)
        6.3.2 World Crispr Genomic Cure Market Size by Application (2024-2029)
        6.3.3 World Crispr Genomic Cure Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Abcam
        7.1.1 Abcam Details
        7.1.2 Abcam Major Business
        7.1.3 Abcam Crispr Genomic Cure Product and Services
        7.1.4 Abcam Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Abcam Recent Developments/Updates
        7.1.6 Abcam Competitive Strengths & Weaknesses
    7.2 Applied StemCel
        7.2.1 Applied StemCel Details
        7.2.2 Applied StemCel Major Business
        7.2.3 Applied StemCel Crispr Genomic Cure Product and Services
        7.2.4 Applied StemCel Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Applied StemCel Recent Developments/Updates
        7.2.6 Applied StemCel Competitive Strengths & Weaknesses
    7.3 Beam Therapeutics
        7.3.1 Beam Therapeutics Details
        7.3.2 Beam Therapeutics Major Business
        7.3.3 Beam Therapeutics Crispr Genomic Cure Product and Services
        7.3.4 Beam Therapeutics Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Beam Therapeutics Recent Developments/Updates
        7.3.6 Beam Therapeutics Competitive Strengths & Weaknesses
    7.4 CALYXT
        7.4.1 CALYXT Details
        7.4.2 CALYXT Major Business
        7.4.3 CALYXT Crispr Genomic Cure Product and Services
        7.4.4 CALYXT Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 CALYXT Recent Developments/Updates
        7.4.6 CALYXT Competitive Strengths & Weaknesses
    7.5 Cellecta
        7.5.1 Cellecta Details
        7.5.2 Cellecta Major Business
        7.5.3 Cellecta Crispr Genomic Cure Product and Services
        7.5.4 Cellecta Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Cellecta Recent Developments/Updates
        7.5.6 Cellecta Competitive Strengths & Weaknesses
    7.6 Cellectis
        7.6.1 Cellectis Details
        7.6.2 Cellectis Major Business
        7.6.3 Cellectis Crispr Genomic Cure Product and Services
        7.6.4 Cellectis Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Cellectis Recent Developments/Updates
        7.6.6 Cellectis Competitive Strengths & Weaknesses
    7.7 CRISPR Therapeutics AG
        7.7.1 CRISPR Therapeutics AG Details
        7.7.2 CRISPR Therapeutics AG Major Business
        7.7.3 CRISPR Therapeutics AG Crispr Genomic Cure Product and Services
        7.7.4 CRISPR Therapeutics AG Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 CRISPR Therapeutics AG Recent Developments/Updates
        7.7.6 CRISPR Therapeutics AG Competitive Strengths & Weaknesses
    7.8 Editas Medicine
        7.8.1 Editas Medicine Details
        7.8.2 Editas Medicine Major Business
        7.8.3 Editas Medicine Crispr Genomic Cure Product and Services
        7.8.4 Editas Medicine Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Editas Medicine Recent Developments/Updates
        7.8.6 Editas Medicine Competitive Strengths & Weaknesses
    7.9 ERS ​​Genomics
        7.9.1 ERS ​​Genomics Details
        7.9.2 ERS ​​Genomics Major Business
        7.9.3 ERS ​​Genomics Crispr Genomic Cure Product and Services
        7.9.4 ERS ​​Genomics Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 ERS ​​Genomics Recent Developments/Updates
        7.9.6 ERS ​​Genomics Competitive Strengths & Weaknesses
    7.10 Integrated DNA Technologies
        7.10.1 Integrated DNA Technologies Details
        7.10.2 Integrated DNA Technologies Major Business
        7.10.3 Integrated DNA Technologies Crispr Genomic Cure Product and Services
        7.10.4 Integrated DNA Technologies Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Integrated DNA Technologies Recent Developments/Updates
        7.10.6 Integrated DNA Technologies Competitive Strengths & Weaknesses
    7.11 Intellia Therapeutics
        7.11.1 Intellia Therapeutics Details
        7.11.2 Intellia Therapeutics Major Business
        7.11.3 Intellia Therapeutics Crispr Genomic Cure Product and Services
        7.11.4 Intellia Therapeutics Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Intellia Therapeutics Recent Developments/Updates
        7.11.6 Intellia Therapeutics Competitive Strengths & Weaknesses
    7.12 Merck KGaA
        7.12.1 Merck KGaA Details
        7.12.2 Merck KGaA Major Business
        7.12.3 Merck KGaA Crispr Genomic Cure Product and Services
        7.12.4 Merck KGaA Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Merck KGaA Recent Developments/Updates
        7.12.6 Merck KGaA Competitive Strengths & Weaknesses
    7.13 New England Biolabs
        7.13.1 New England Biolabs Details
        7.13.2 New England Biolabs Major Business
        7.13.3 New England Biolabs Crispr Genomic Cure Product and Services
        7.13.4 New England Biolabs Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 New England Biolabs Recent Developments/Updates
        7.13.6 New England Biolabs Competitive Strengths & Weaknesses
    7.14 Precision BioSciences
        7.14.1 Precision BioSciences Details
        7.14.2 Precision BioSciences Major Business
        7.14.3 Precision BioSciences Crispr Genomic Cure Product and Services
        7.14.4 Precision BioSciences Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Precision BioSciences Recent Developments/Updates
        7.14.6 Precision BioSciences Competitive Strengths & Weaknesses
    7.15 Sangamo Therapeutics
        7.15.1 Sangamo Therapeutics Details
        7.15.2 Sangamo Therapeutics Major Business
        7.15.3 Sangamo Therapeutics Crispr Genomic Cure Product and Services
        7.15.4 Sangamo Therapeutics Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Sangamo Therapeutics Recent Developments/Updates
        7.15.6 Sangamo Therapeutics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Crispr Genomic Cure Industry Chain
    8.2 Crispr Genomic Cure Upstream Analysis
    8.3 Crispr Genomic Cure Midstream Analysis
    8.4 Crispr Genomic Cure Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Crispr Genomic Cure Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Crispr Genomic Cure Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Crispr Genomic Cure Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Crispr Genomic Cure Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Crispr Genomic Cure Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Crispr Genomic Cure Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Crispr Genomic Cure Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Crispr Genomic Cure Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Crispr Genomic Cure Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Crispr Genomic Cure Players in 2022
    Table 12. World Crispr Genomic Cure Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Crispr Genomic Cure Company Evaluation Quadrant
    Table 14. Head Office of Key Crispr Genomic Cure Player
    Table 15. Crispr Genomic Cure Market: Company Product Type Footprint
    Table 16. Crispr Genomic Cure Market: Company Product Application Footprint
    Table 17. Crispr Genomic Cure Mergers & Acquisitions Activity
    Table 18. United States VS China Crispr Genomic Cure Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Crispr Genomic Cure Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Crispr Genomic Cure Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Crispr Genomic Cure Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Crispr Genomic Cure Revenue Market Share (2018-2023)
    Table 23. China Based Crispr Genomic Cure Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Crispr Genomic Cure Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Crispr Genomic Cure Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Crispr Genomic Cure Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Crispr Genomic Cure Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Crispr Genomic Cure Revenue Market Share (2018-2023)
    Table 29. World Crispr Genomic Cure Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Crispr Genomic Cure Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Crispr Genomic Cure Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Crispr Genomic Cure Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Crispr Genomic Cure Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Crispr Genomic Cure Market Size by Application (2024-2029) & (USD Million)
    Table 35. Abcam Basic Information, Area Served and Competitors
    Table 36. Abcam Major Business
    Table 37. Abcam Crispr Genomic Cure Product and Services
    Table 38. Abcam Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Abcam Recent Developments/Updates
    Table 40. Abcam Competitive Strengths & Weaknesses
    Table 41. Applied StemCel Basic Information, Area Served and Competitors
    Table 42. Applied StemCel Major Business
    Table 43. Applied StemCel Crispr Genomic Cure Product and Services
    Table 44. Applied StemCel Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Applied StemCel Recent Developments/Updates
    Table 46. Applied StemCel Competitive Strengths & Weaknesses
    Table 47. Beam Therapeutics Basic Information, Area Served and Competitors
    Table 48. Beam Therapeutics Major Business
    Table 49. Beam Therapeutics Crispr Genomic Cure Product and Services
    Table 50. Beam Therapeutics Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Beam Therapeutics Recent Developments/Updates
    Table 52. Beam Therapeutics Competitive Strengths & Weaknesses
    Table 53. CALYXT Basic Information, Area Served and Competitors
    Table 54. CALYXT Major Business
    Table 55. CALYXT Crispr Genomic Cure Product and Services
    Table 56. CALYXT Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. CALYXT Recent Developments/Updates
    Table 58. CALYXT Competitive Strengths & Weaknesses
    Table 59. Cellecta Basic Information, Area Served and Competitors
    Table 60. Cellecta Major Business
    Table 61. Cellecta Crispr Genomic Cure Product and Services
    Table 62. Cellecta Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Cellecta Recent Developments/Updates
    Table 64. Cellecta Competitive Strengths & Weaknesses
    Table 65. Cellectis Basic Information, Area Served and Competitors
    Table 66. Cellectis Major Business
    Table 67. Cellectis Crispr Genomic Cure Product and Services
    Table 68. Cellectis Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Cellectis Recent Developments/Updates
    Table 70. Cellectis Competitive Strengths & Weaknesses
    Table 71. CRISPR Therapeutics AG Basic Information, Area Served and Competitors
    Table 72. CRISPR Therapeutics AG Major Business
    Table 73. CRISPR Therapeutics AG Crispr Genomic Cure Product and Services
    Table 74. CRISPR Therapeutics AG Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. CRISPR Therapeutics AG Recent Developments/Updates
    Table 76. CRISPR Therapeutics AG Competitive Strengths & Weaknesses
    Table 77. Editas Medicine Basic Information, Area Served and Competitors
    Table 78. Editas Medicine Major Business
    Table 79. Editas Medicine Crispr Genomic Cure Product and Services
    Table 80. Editas Medicine Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Editas Medicine Recent Developments/Updates
    Table 82. Editas Medicine Competitive Strengths & Weaknesses
    Table 83. ERS ​​Genomics Basic Information, Area Served and Competitors
    Table 84. ERS ​​Genomics Major Business
    Table 85. ERS ​​Genomics Crispr Genomic Cure Product and Services
    Table 86. ERS ​​Genomics Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. ERS ​​Genomics Recent Developments/Updates
    Table 88. ERS ​​Genomics Competitive Strengths & Weaknesses
    Table 89. Integrated DNA Technologies Basic Information, Area Served and Competitors
    Table 90. Integrated DNA Technologies Major Business
    Table 91. Integrated DNA Technologies Crispr Genomic Cure Product and Services
    Table 92. Integrated DNA Technologies Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Integrated DNA Technologies Recent Developments/Updates
    Table 94. Integrated DNA Technologies Competitive Strengths & Weaknesses
    Table 95. Intellia Therapeutics Basic Information, Area Served and Competitors
    Table 96. Intellia Therapeutics Major Business
    Table 97. Intellia Therapeutics Crispr Genomic Cure Product and Services
    Table 98. Intellia Therapeutics Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Intellia Therapeutics Recent Developments/Updates
    Table 100. Intellia Therapeutics Competitive Strengths & Weaknesses
    Table 101. Merck KGaA Basic Information, Area Served and Competitors
    Table 102. Merck KGaA Major Business
    Table 103. Merck KGaA Crispr Genomic Cure Product and Services
    Table 104. Merck KGaA Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Merck KGaA Recent Developments/Updates
    Table 106. Merck KGaA Competitive Strengths & Weaknesses
    Table 107. New England Biolabs Basic Information, Area Served and Competitors
    Table 108. New England Biolabs Major Business
    Table 109. New England Biolabs Crispr Genomic Cure Product and Services
    Table 110. New England Biolabs Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. New England Biolabs Recent Developments/Updates
    Table 112. New England Biolabs Competitive Strengths & Weaknesses
    Table 113. Precision BioSciences Basic Information, Area Served and Competitors
    Table 114. Precision BioSciences Major Business
    Table 115. Precision BioSciences Crispr Genomic Cure Product and Services
    Table 116. Precision BioSciences Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Precision BioSciences Recent Developments/Updates
    Table 118. Sangamo Therapeutics Basic Information, Area Served and Competitors
    Table 119. Sangamo Therapeutics Major Business
    Table 120. Sangamo Therapeutics Crispr Genomic Cure Product and Services
    Table 121. Sangamo Therapeutics Crispr Genomic Cure Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 122. Global Key Players of Crispr Genomic Cure Upstream (Raw Materials)
    Table 123. Crispr Genomic Cure Typical Customers
List of Figure
    Figure 1. Crispr Genomic Cure Picture
    Figure 2. World Crispr Genomic Cure Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Crispr Genomic Cure Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Crispr Genomic Cure Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Crispr Genomic Cure Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Crispr Genomic Cure Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Crispr Genomic Cure Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Crispr Genomic Cure Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Crispr Genomic Cure Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Crispr Genomic Cure Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Crispr Genomic Cure Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Crispr Genomic Cure Revenue (2018-2029) & (USD Million)
    Figure 13. Crispr Genomic Cure Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Crispr Genomic Cure Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Crispr Genomic Cure Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Crispr Genomic Cure Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Crispr Genomic Cure Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Crispr Genomic Cure Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Crispr Genomic Cure Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Crispr Genomic Cure Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Crispr Genomic Cure Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Crispr Genomic Cure Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Crispr Genomic Cure by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Crispr Genomic Cure Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Crispr Genomic Cure Markets in 2022
    Figure 27. United States VS China: Crispr Genomic Cure Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Crispr Genomic Cure Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Crispr Genomic Cure Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Crispr Genomic Cure Market Size Market Share by Type in 2022
    Figure 31. gRNA Design and Vector Construction
    Figure 32. Cell Line and Engineering
    Figure 33. Others
    Figure 34. World Crispr Genomic Cure Market Size Market Share by Type (2018-2029)
    Figure 35. World Crispr Genomic Cure Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 36. World Crispr Genomic Cure Market Size Market Share by Application in 2022
    Figure 37. Biomedical
    Figure 38. Pharmaceutical
    Figure 39. Agricultural
    Figure 40. Others
    Figure 41. Crispr Genomic Cure Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source